Baroda, India

Natarajan Arulsudar

USPTO Granted Patents = 3 


Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Baroda, IN (2013 - 2014)
  • Kodichikkanahalli, IN (2022)

Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Natarajan Arulsudar: Innovator in Nanodispersion Technology

Introduction

Natarajan Arulsudar is a prominent inventor based in Baroda, India. He has made significant contributions to the field of medical treatments, particularly in the area of cancer therapy. With a total of 3 patents to his name, his work focuses on innovative methods of drug delivery.

Latest Patents

One of his latest patents is titled "Method of treating carcinoma." This invention outlines a method for treating patients suffering from carcinoma of the intrahepatic or extrahepatic bile duct or gall bladder, which is locally advanced or metastatic. The method involves intravenously administering paclitaxel in the form of a nanodispersion. This nanodispersion comprises particles with a mean particle size of less than 300 nm and is free of polyoxyethylated castor oil and protein. Another notable patent is "Nanodispersion of a drug and process for its preparation." This patent describes a nanodispersion containing nanoparticles with a mean size of less than 300 nm, dispersed in a vehicle that includes a water-miscible solvent and water. The nanoparticles consist of one or more drugs, a polymer, and a surfactant, which includes a mixture of fatty acids or their salts and sterols or their derivatives.

Career Highlights

Natarajan Arulsudar is currently associated with Sun Pharma Advanced Research Company Limited, where he continues to innovate and develop new therapeutic solutions. His work has been instrumental in advancing the field of nanotechnology in medicine.

Collaborations

He has collaborated with notable colleagues such as Ajay Khopade and Subhas Balaram Bhowmick, contributing to a dynamic research environment that fosters innovation.

Conclusion

Natarajan Arulsudar's contributions to the field of nanodispersion technology and cancer treatment exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to improving patient outcomes through advanced drug delivery methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…